BostInno’s State of Innovation

Related Posts

01 Aug

Myomo, Inc. Obtains CE Mark Approval for MyoPro®

Myomo, Inc. (NYSE MKT:MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it has…

read more
15 May

Corbus Pharmaceuticals Gets a Buy Rating from Noble Financial

Corbus Pharmaceuticals Holdings, Inc. engages in the development and commercialization of novel therapeutics to treat rare or uncommon chronic…

read more
10 Sep

eSight device helps Cheyenne teen see a new world

Sven Sansa, 15, who has rod cone dystrophy, wears his new eSight glasses, which greatly improve his ability to…

read more
20 Jun

Blind Guilford Teen Can Now See Thanks to High-Tech Pair of Glasses

Blind Guilford Teen Can Now See Thanks to High-Tech Pair of Glasses. Read more >>

read more
21 Jul

Johns Hopkins spinout Neuraly launches with $36M funding round

The Maryland biotech startup is developing new treatments for Parkinson’s disease and Alzheimer’s disease. Read more >>

read more
21 Nov

Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today that the first of 100 subjects…

read more
06 Sep

ENTREVESTOR: Innovative companies hit stage in Halifax

A startup event is taking place in Halifax next Monday that isn’t really about startups. It’s a showcase for…

read more
13 Feb

Hoth Therapeutics Announces Positive Preliminary, Preclinical Data on its Therapeutic for Cutaneous Lupus Erythematosus (CLE), a Chronic Autoimmune Skin Disease

The study conducted in partnership with Zylö Therapeutics confirmed AEA-loaded in Z-pods™ provides an actual reduction in lesion score….

read more
16 Jun

A health tech accelerator takes root in Amish country to support clinical validation

The Lab’s first cohort includes two companies — Philadelphia-based behavioral health startup NeuroFlow and Emovi, a Canadian medical device…

read more
04 Nov

PlateletBio Completes $75.5M Series B Financing

PlateletBio, a preclinical-stage biotechnology company pioneering an entirely new platform of allogeneic cell therapies based on platelet biology, today…

read more